Related Experiment Video
Updated: Jun 16, 2025
High-resolution Single Particle Analysis from Electron Cryo-microscopy Images Using SPHIRE
Published on: May 16, 2017
Structural analysis of the human C5a-C5aR1 complex using cryo-electron microscopy
Tingting Yang1, Jian Li2, Xinyu Cheng1
1The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330031, China; The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
Researchers elucidated the structure of the C5a-C5aR1-Gi complex using cryo-electron microscopy. This reveals key insights into complement system function and potential drug targets for immune response modulation.
Area of Science:
- Immunology
- Structural Biology
- Biochemistry
Background:
- The complement system is vital for innate immunity, with the C5a-C5aR1 complex mediating immune cell recruitment and activation.
- Understanding C5a-C5aR1 activation and signaling is crucial for C5a-mediated disease research.
Purpose of the Study:
- To determine the high-resolution structure of the C5a-C5aR1-Gi complex.
- To investigate the C5a binding site and its impact on receptor conformation and signaling.
- To identify key residues regulating C5a-mediated signaling pathways.
Main Methods:
- Cryo-electron microscopy (Cryo-EM) was employed to determine the structure of the C5a-C5aR1-Gi complex at 3 Å resolution.
Main Results:
- The study identified the C5a binding site, involving extracellular polar interactions and a transmembrane amphipathic pocket.
- C5a binding induces conformational changes in C5aR1, activating G protein signaling.
- Residue M265 on TM6 was found to be critical for regulating C5a-induced β-arrestin recruitment.
Conclusions:
- This research provides detailed structural and functional information on the human C5a-C5aR1 complex, essential for complement system function.
- The findings offer a foundation for developing targeted pharmaceuticals with specific or biased signaling for the C5a receptor.
